Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study.

Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study.

<h4>Introduction</h4>Germline BRCA1/2-associated epithelial ovarian cancer has been associated with better progression-free survival and overall survival than sporadic epithelial ovarian cancer, but conclusive data are lacking.<h4>Methods</h4>We matched 389 BRCA1-associated a...

Full description

Bibliographic Details
Main Authors:	Bernadette A M Heemskerk-Gerritsen, Antoinette Hollestelle, Christi J van Asperen, Irma van den Beek, Willemien J van Driel, Klaartje van Engelen, Encarna B Gómez Garcia, Joanne A de Hullu, Marco J Koudijs, Marian J E Mourits, Maartje J Hooning, Ingrid A Boere
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0275015

Similar Items

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study
by: Delal Akdeniz, et al.
Published: (2022-02-01)

Corrigendum to “The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer” [Breast 52 (2020) 102–109]
by: Mark van Barele, et al.
Published: (2020-10-01)

Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a <i>BRCA1/2</i> Mutation
by: Shuoying Qu, et al.
Published: (2023-12-01)

Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study)
by: Terra, Lara, et al.
Published: (2021-01-01)

The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families
by: Maartje A.C. Schreurs, et al.
Published: (2024-02-01)

Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
by: Mark van Barele, et al.
Published: (2021-05-01)

Winter survival of individual honey bees and honey bee colonies depends on level of Varroa destructor infestation.
by: Coby van Dooremalen, et al.
Published: (2012-01-01)

The effect of attendance in the Dutch breast cancer screening program on breast tumor characteristics among migrant women
by: R.R.E. Dassen, et al.
Published: (2023-06-01)

Modelling survival and connectivity of <i>Mnemiopsis leidyi</i> in the south-western North Sea and Scheldt estuaries
by: J. van der Molen, et al.
Published: (2015-06-01)

Impact of BRCA1 mutation on survival after early onset breast cancer
by: Huzarski T, et al.
Published: (2012-12-01)

Identifying Transcripts with Tandem Duplications from RNA-Sequencing Data to Predict BRCA1-Type Primary Breast Cancer
by: Shuoying Qu, et al.
Published: (2022-01-01)

Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.
by: Alexandra J van den Broek, et al.
Published: (2015-01-01)

The Effect of Risk-Reducing Salpingo-Oophorectomy on Breast Cancer Incidence and Histopathological Features in Women with a <i>BRCA1</i> or <i>BRCA2</i> Germline Pathogenic Variant
by: Annechien Stuursma, et al.
Published: (2023-03-01)

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
by: Nasim Mavaddat, et al.
Published: (2020-02-01)

Dynamic prediction in clinical survival analysis /
by: Houwelingen, J. C. van, et al.
Published: (c201)

The progression-free survival ratio as outcome measure in recurrent ovarian carcinoma patients: Current and future perspectives
by: Nienke van de Kruis, et al.
Published: (2022-08-01)

Survival of Women with Advanced Stage Cervical Cancer: Neo-Adjuvant Chemotherapy Followed by Radiotherapy and Hyperthermia versus Chemoradiotherapy
by: Jonathan Servayge, et al.
Published: (2024-02-01)

Distinct Genomic Profiles Are Associated with Treatment Response and Survival in Ovarian Cancer
by: Chris J. de Witte, et al.
Published: (2022-03-01)

Common sole larvae survive high levels of pile-driving sound in controlled exposure experiments.
by: Loes J Bolle, et al.
Published: (2012-01-01)

Recontacting non-BRCA1/2 breast cancer patients for germline CHEK2 c.1100del pathogenic variant testing: uptake and patient experiences
by: Mary E. Velthuizen, et al.
Published: (2021-01-01)

A multi-center study to evaluate the impact of germline BRCA1 and BRCA2 mutations on ovarian cancer survival
by: Bolton KL, et al.
Published: (2012-04-01)

Effect of a health literacy training program for surgical oncologists and specialized nurses on disparities in referral to breast cancer genetic testing
by: Jeanine A.M. van der Giessen, et al.
Published: (2021-08-01)

Evolutionary economics and environmental policy : survival of the greenest /
by: Bergh, Jeroen C. J. M. van den, 1965-
Published: (2007)

Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer
by: Tingyan Shi, et al.
Published: (2018-07-01)

Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
by: Yong Jae Lee, et al.
Published: (2020-03-01)

Decreased Survival and Lung Function in Progressive Pulmonary Fibrosis
by: Mark G. J. P. Platenburg, et al.
Published: (2023-02-01)

Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls
by: van der Wall Elsken, et al.
Published: (2010-04-01)

Effect of intraperitoneal chemotherapy concentration on morbidity and survival
by: F. M. K. Elekonawo, et al.
Published: (2020-04-01)

Identification of Lifestyle Behaviors Associated with Recurrence and Survival in Colorectal Cancer Patients Using Random Survival Forests
by: Moniek van Zutphen, et al.
Published: (2021-05-01)

HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.
by: Petra van der Groep, et al.
Published: (2013-01-01)

De toekomst verslagen
by: P. Van Asperen, et al.
Published: (2004-01-01)

Correction: Feed Conversion, Survival and Development, and Composition of Four Insect Species on Diets Composed of Food By-Products.
by: Dennis G A B Oonincx, et al.
Published: (2019-01-01)

Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort
by: Delal Akdeniz, et al.
Published: (2023-02-01)

Plant Mediated Interactions: Lower Sawfly Survival on Pines Previously Browsed by Moose
by: Michelle Nordkvist, et al.
Published: (2021-04-01)

Survival Processing and the Stroop Task
by: Stephanie A. Kazanas, et al.
Published: (2015-11-01)

Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies
by: Gonzalez-Neira Anna, et al.
Published: (2007-08-01)

Metastatic Uveal Melanoma: Treatment Strategies and Survival—Results from the Dutch Melanoma Treatment Registry
by: Anouk Jochems, et al.
Published: (2019-07-01)

Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival
by: Marcelo Sobral-Leite, et al.
Published: (2018-12-01)

Zoledronic acid prevents the development of myeloma bone disease and increases survival
by: Shipman, C, et al.
Published: (2002)

Cancer Spectrum, Family History of Cancer and Overall Survival in Men with Germline <i>BRCA1</i> or <i>BRCA2</i> Mutations
by: Florian Reichl, et al.
Published: (2021-09-01)